EF Hutton Initiates Coverage On OS Therapies with Buy Rating, Announces Price Target of $21
Portfolio Pulse from Benzinga Newsdesk
EF Hutton has initiated coverage on OS Therapies (AMEX:OSTX) with a Buy rating and set a price target of $21. This suggests a positive outlook for the company's stock.
September 03, 2024 | 1:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
EF Hutton has initiated coverage on OS Therapies with a Buy rating and a price target of $21, indicating a positive outlook for the stock.
The initiation of coverage with a Buy rating and a specific price target of $21 by EF Hutton suggests confidence in OS Therapies' future performance. This is likely to positively influence investor sentiment and could lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100